LGND Ligand Pharmaceuticals Incorporated
Healthcare$229.33+3.22%ClosedMarket Cap: $4.60B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$267.75
Target (Median)
$265.00
Target Range
$252.00 - $289.00
Upside from current price: 16.8%
Rating Distribution
2 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-08 | RBC Capital | maintain | Outperform | Outperform |
| 2026-04-30 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-15 | Citigroup | maintain | Buy | Buy |
| 2026-02-27 | Oppenheimer | maintain | Outperform | Outperform |
| 2026-02-24 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-12-10 | Stifel | maintain | Buy | Buy |
| 2025-12-10 | RBC Capital | maintain | Outperform | Outperform |
| 2025-11-07 | Benchmark | maintain | Buy | Buy |
| 2025-11-07 | Oppenheimer | maintain | Outperform | Outperform |
| 2025-11-06 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $11.16 | $364.2M | 5 |
| Sun Dec 31 | $12.88 | $434.1M | 4 |
| Mon Dec 31 | $13.81 | $510.9M | 2 |
| Tue Dec 31 | $16.68 | $506.4M | 2 |